ConvaTec Group (CTEC.L:LSE) Investor Relations Material

Overview

Medical products and technologies manufacturer, ConvaTec Group PLC, has announced its commitment to global health through the development, manufacture, and marketing of a variety of advanced wound dressings, skin care products, ostomy care solutions, continence and critical care products and services, and infusion care solutions. The company's products cater to acute and chronic wounds arising from various conditions, such as diabetes, traumatic injury, and burns, as well as ostomy care solutions for people with a stoma resulting from colorectal cancer and inflammatory bowel disease. Additionally, the company provides continence and critical care products and services for people with urinary continence issues and infusion care solutions for continuous subcutaneous infusion treatments. ConvaTec Group PLC sells its products to a range of customers, including healthcare providers, patients, and manufacturers, directly or through distributors and wholesalers. The company's headquarters are in Reading, United Kingdom, and it was founded in 1978.

Frequently Asked Questions

What is ConvaTec Group's ticker?

ConvaTec Group's ticker is CTEC.L

What exchange is ConvaTec Group traded on?

The company's shares trade on the LSE stock exchange

Where are ConvaTec Group's headquarters?

They are based in Reading, England

How many employees does ConvaTec Group have?

There are 5001-10,000 employees working at ConvaTec Group

What is ConvaTec Group's website?

It is https://convatecgroup.com/

What type of sector is ConvaTec Group?

ConvaTec Group is in the Healthcare sector

What type of industry is ConvaTec Group?

ConvaTec Group is in the Medical Instruments & Supplies industry

Who are ConvaTec Group's peers and competitors?

The following five companies are ConvaTec Group's industry peers:

- Harvard Bioscience

- Ansell

- iRhythm

- Antares Pharma Inc.

- Cantel Medical Corp.